Assess the Potential for Adrenal Suppression and Systemic Drug Absorption Following Multiple Dosing With DFD-06

NCT03179605 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

22

Enrollment

INDUSTRY

Sponsor class

Stopped Difficulty in enrollment

Conditions

Psoriasis

Interventions

DRUG: DFD06

Sponsor

Primus Pharmaceuticals

Collaborators

[object Object]